EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rare but relevant: a comprehensive narrative review of rare HIV-1 group M subtypes

Dana F Indihar iD, Rachael Oke, Rondel Hemerding, De'Travean Williams, Rupert England, Laricca Y London

mBio · 08.10.2025 · 16 (10)

DOI: 10.1128/mbio.01264-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift mBio, erschienen am 08.10.2025. Verfasst von Dana F Indihar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Alabama A&M University, Huntsville, Alabama, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Genetic Variation, Genotype. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human immunodeficiency virus type 1 (HIV-1) group M comprises 10 genetically diverse subtypes, with subtypes C and B being the most prevalent globally. However, rare subtypes F, H, J, K, and L, though individually responsible for less than 1% of HIV-1 infections worldwide, play relevant roles in viral evolution, global persistence, recombination, and drug resistance. This review provides a comprehensive synthesis of the available literature on these rare subtypes for the first time, emphasizing their distribution, recombination patterns, transmission dynamics, and drug resistance-associated mutations. A key observation is that many of these rare subtypes are more frequently found in recombinant forms than in non-recombinant forms, which may expand their geographic distribution and sustain their epidemiological presence. We further highlight drug resistance-associated mutations in the protease and reverse transcriptase regions of the rare subtypes, which may affect treatment outcomes. Advances in molecular tools, such as next-generation sequencing and Bayesian phylogeographic analyses, have improved the identification of the rare subtypes in both recombinant and non-recombinant forms. However, there remains a significant data gap in the clinical impact of these subtypes as they continue to be undersampled and understudied. This review thus underscores the need for augmenting subtype-specific surveillance strategies, especially in regions where the rare subtypes predominantly circulate. Expanding research on these rare subtypes will be essential for understanding HIV-1 recombination and evolutionary dynamics, identifying trends in drug resistance, and developing more globally inclusive anti-viral strategies that better reflect the diversity of HIV-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsGenetic VariationGenotypeHumansDrug Resistance, ViralRecombination, GeneticPhylogenyMutationEvolution, MolecularAnti-HIV Agents

Stichwörter der Autor:innen

genetic recombinationhuman immunodeficiency virusmultidrug resistancephylogenetic analysisrare subtypes

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, Alabama A&M University, Huntsville, Alabama, USA.

ORCID-Profile: Dana F Indihar

Zitieren

APA

Indihar, D. F., Oke, R., Hemerding, R., Williams, D., England, R., & London, L. Y. (2025). Rare but relevant: a comprehensive narrative review of rare HIV-1 group M subtypes. mBio, 16(10). https://doi.org/10.1128/mbio.01264-25

Vancouver

Indihar DF, Oke R, Hemerding R, Williams D, England R, London LY. Rare but relevant: a comprehensive narrative review of rare HIV-1 group M subtypes. mBio. 2025;16(10). doi:10.1128/mbio.01264-25

BibTeX
@article{Indihar2025,
  author = {Indihar, Dana F and Oke, Rachael and Hemerding, Rondel and Williams, De'Travean and England, Rupert and London, Laricca Y},
  title = {Rare but relevant: a comprehensive narrative review of rare HIV-1 group M subtypes},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {10},
  doi = {10.1128/mbio.01264-25}
}
Kostenlos starten →